Next Generation Biobanking
We connect biobanks in Germany and Europe.
Our mission is to support biomedical research.
From the donor to the researcher: all stakeholders are included in GBN.
The lung disease Covid-19, which is caused by the novel coronavirus known as SARS-CoV-2, has the world in its grip. GBN is bringing biobanks and researchers together to gain insights into the disease and develop treatments.
The quality of samples is of paramount importance for the success of biomedical research.
Biobanks need a networked IT infrastructure to exchange data efficiently. This allows large multi-centric collections of samples to be assembled for research purposes.
New technologies are set to change the face of biobanking in the years ahead. This raises many ethical, legal and social issues that need to be addressed in dialogue with patient representatives, scientists, privacy advocates and the general public.
Biobanks need the commitment and involvement of diverse stakeholders. Stakeholder engagement is a critical factor for the success of a biobank.
Training and education
Biobanks need qualified personnel to ensure a high samples quality. We support biobanks in the development of training programmes for their technical staff.